Abstract
Gonorrhoea is a global public health challenge. In 2020, an annual incidence of 82 million gonorrhoea cases among adults was estimated globally.1 The highest disability-adjusted life-years (DALYs) is reported in sub-Saharan Africa, southeast Asia, and Oceania.2 Gonorrhoea disproportionately affects subpopulations, including young adults, men who have sex with men (MSM), transgender people, sex workers, people living with HIV, and socioeconomically disadvantaged people. There is urgency in controlling gonorrhoea because of the increasing antimicrobial resistance and potential to become untreatable.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
